Percutaneous Strategies in Structural Heart Diseases: Focus on Chronic Heart Failure

• Published in: Arquivos brasileiros de cardiologia Vol. 120; no. 11; p. e20220496
• Main Authors: Filippini, Filippe Barcellos, Ribeiro, Henrique Barbosa, Bocchi, Edimar, Bacal, Fernando, Marcondes-Braga, Fabiana G, Avila, Monica S, Sturmer, Janine Daiana, Marchi, Mauricio Felippi de Sá, Kanhouche, Gabriel, Freire, Antônio Fernando, Cassar, Renata, Abizaid, Alexandre A, Brito, Jr, Fábio Sândoli de
• Format: Journal Article
• Language: Portuguese; English
• Published: Brazil 01.11.2023
• Subjects: Heart Atria; Heart Failure - therapy; Humans; Kidney; Sympathectomy
• ISSN: 1678-4170
• DOI: 10.36660/abc.20220496

Central Illustration : Percutaneous Strategies in Structural Heart Diseases: Focus on Chronic Heart Failure Transcatheter devices for monitoring and treating advanced chronic heart failure patients. PA: pulmonary artery; LA: left atrium; AFR: atrial flow regulator; TASS: Transcatheter Atrial Shunt System; VNS: vagus nerve stimulation; BAT: baroreceptor activation therapy; RDN: renal sympathetic denervation; F: approval by the American regulatory agency (FDA); E: approval by the European regulatory agency (CE Mark). Innovations in devices during the last decade contributed to enhanced diagnosis and treatment of patients with cardiac insufficiency. These tools progressively adapted to minimally invasive strategies with rapid, widespread use. The present article focuses on actual and future directions of device-related diagnosis and treatment of chronic heart failure.